Business Context and Reporting Period
This Form 8-K Current Report was filed by Ares Capital Corporation on February 16, 2021. The filing discloses a significant capital raising event involving the issuance of common stock.
Key Financial Metrics
- Shares Issued: 13,500,000 shares of common stock.
- Offering Price: $17.85 per share.
- Net Proceeds: Approximately $240.5 million (after deducting discounts, commissions, and estimated offering expenses).
- Over-Allotment Option: Underwriters were granted an option to purchase an additional 2,025,000 shares, exercisable for 30 days from the Purchase Agreement date.
Material Changes
The primary material change reported is the increase in equity capital resulting from the underwritten public offering. The filing does not provide comparative financial data (e.g., revenue, profit, or debt levels) for the prior period as this is a transaction-specific report rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors beyond the standard disclosures associated with the equity offering. The transaction was executed pursuant to a Purchase Agreement dated February 10, 2021, with underwriters including BofA Securities, Inc., Morgan Stanley & Co. LLC, and Wells Fargo Securities LLC.
Investor Verification Checklist
- Verify the final exercise status of the 2,025,000 share over-allotment option.
- Review the full text of the Purchase Agreement (Exhibit 1.1) for specific covenants or conditions.
- Confirm the use of the $240.5 million in net proceeds in subsequent quarterly reports.
- Check for any dilution impact on earnings per share in the next earnings release.